Danel (Adir Yeoshua) Ltd (TLV:DANE)
41,050
+530 (1.31%)
Jun 4, 2025, 3:49 PM IDT
Danel (Adir Yeoshua) Revenue
Danel (Adir Yeoshua) had revenue of 704.34M ILS in the quarter ending March 31, 2025, with 5.89% growth. This brings the company's revenue in the last twelve months to 2.81B, up 9.32% year-over-year. In the year 2024, Danel (Adir Yeoshua) had annual revenue of 2.77B with 10.20% growth.
Revenue (ttm)
2.81B
Revenue Growth
+9.32%
P/S Ratio
0.85
Revenue / Employee
654.85K
Employees
4,290
Market Cap
2.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.77B | 256.31M | 10.20% |
Dec 31, 2023 | 2.51B | 149.89M | 6.34% |
Dec 31, 2022 | 2.36B | 75.20M | 3.29% |
Dec 31, 2021 | 2.29B | 303.89M | 15.31% |
Dec 31, 2020 | 1.98B | 306.79M | 18.28% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 61.87B |
Kamada | 622.70M |
Bait Bakfar | 104.50M |
SofWave Medical | 235.09M |
BrainsWay | 161.81M |
Novolog (Pharm-Up 1966) | 2.07B |
Ilex Medical | 922.08M |
InterCure | 238.85M |